Table II. Antipsychotic side effects and quality of life. MLDL, Munich Quality of Life Dimensions; PGWB, Psychological General Well-Being Index; Q-LES-Q, Quality of Life Enjoyment and Satisfaction Questionnaire; QLS, Quality of Life Scale; QoL, Quality of Life; QoLI, Lehman Quality of Life Interview; SF-12, Short-Form; SF-36, Short-Form 36; SQLS, Schizophrenia Quality of Life Scale; UKU, The UKU Side-Effect Rating Scale; VAS-QoL, Visual Analogue Scale Quality of Life.
| Author, year | Patient (number) | Side effects/Scale | Quality of Life scale | Influence on Quality of Life? |
| Browne, 19966 | 64 | Tardive dyskinesia/Abnormal Involuntary Movements Scale | QLS | Yes |
| Larsen, 199655 | 53 | UKU | PGBW | No |
| Awad, 199712 | 63 | Akathisia (Hillside Akathisia Scale) | Gurin's global QoL | Yes |
| Franz, 199754 | 64 | Extrapyramidal | MLDL | No |
| Revicki, 199922 | 828 | Extrapyremidal/Simpson-Angus Scale | QLS | Yes |
| Kaneda, 200356 | 42 | Hyperprolactinemia | SQLS | No |
| Ritsner, 200336 | 148 | Number of adverse symptoms | Q-LES-Q | Yes |
| Allison, 200357 | 286 | Weight gain | PGWB, VAS-QoL | Yes |
| Strassnig, 200358 | 143 | Body weight / Body mass index | SF-36 | Yes |
| Meyer, 200559 | 1231 | Metabolic syndrome | SF-12 | Yes |
| Olfson, 200560 | 139 | Male sexual dysfunction / Change in Sexual Functioning Questionnaire | QoLI | Yes |